Kenvue Inc.
Kenvue Inc. is classed by the SEC under Perfumes, Cosmetics & Other Toilet Preparations (industry code 2844), based in Summit, NJ. In its latest annual figures on file, for the fiscal year ended 2025-12-28, it reported revenue of $15 billion and a profit of $1.5 billion (its filed statements).
vs its business-model standard
Three tenses, nine metrics. Unseen metrics stay unseen; the grade never fakes a number. Proxy era: provisional values, marked. Weighed as a product business: prior from its industry code (SEC 2844, Perfumes, Cosmetics & Other Toilet Preparations); the filing read can change it. All three tenses have at least two readings, so the archetype blend applies as printed.
The grade, in three tenses
Headline 5.0 out of ten, 9 of 9 metrics filed: past 5.8 out of ten, present 5.1 out of ten, future 4.3 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.
The nine metrics
- Surviving crises (past): 7.2 out of ten. No warning events in its filings since 2022. 72nd percentile among 18 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Track record (past): 5.0 out of ten. +0.1% a year over 5 filed years; profitable in 5 of 5. 50th percentile among 16 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Shareholder treatment (past): 5.1 out of ten. Share count grew 3.9% a year. 61% of cash flow returned. Insiders: 2 sales, 2 purchases. 51st percentile among 11 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Financial health (present): 4.9 out of ten. ROE 14%: 14¢ of profit per shareholder dollar. Leverage 60%: owes 60¢ per asset dollar. 49th percentile among 17 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Industry position (present): 6.0 out of ten. top 40% of 17 in its family; net margin 9.7%. 60th percentile among 17 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Leadership (present): 4.2 out of ten. bottom 42% of 10 in its family for leadership; chief executive since 2025. 42nd percentile among 10 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-09).
- Room to expand (future): 4.1 out of ten. bottom 41% of 17 in its family for room to expand. 41st percentile among 17 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Growth drivers (future): 4.5 out of ten. bottom 45% of 16 in its family for growth drivers. 45th percentile among 16 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Expectations vs reality (future): 4.5 out of ten. bottom 45% of 16 in its family for expectations against reality. 45th percentile among 16 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
The filing record
Newest annual report: Form 10-K filed 2026-02-20 for the period ended 2025-12-28 (on EDGAR). Newest quarterly report: Form 10-Q filed 2026-08-06 for the period ended 2026-06-28 (on EDGAR). Newest results release: Form 8-K filed 2026-08-06 (on EDGAR). Newest filing: Form 4, 2026-10-06. Filings on record since 2022. Read from EDGAR 2026-10-12.
Where the revenue comes from
Lines of business in fiscal 2025: Self Care 42%, Essential Health 31%, Skin Health and Beauty 27%. By geography: North America 48%, Europe, Middle East, and Africa 25%, Asia-Pacific 18%, Latin America 9%. As tagged in its annual report (Form 10-K, filed 2026-02-20).
Who runs it
Perry, Kirk (Chief Executive Officer); Lawson, Carlton (Group President EMEA & LA); Dasgupta, Anindya (Group President APAC); Curado, Gomes De Lemos Leonardo (Group President LATAM); De, Jesus Carlos (Group President North America); Howlett, Heather (CFO & CAO); Banati, Amit (Chief Financial Officer); Stevens, Meredith (Chief Operations Officer); Tillett, Caroline (Chief Scientific Officer); Wondrasch, Michael (Chief Tech & Data Officer); and 15 more. 25 officers and directors have filed their own trades in the last fifteen months, names and titles as filed with the SEC, through 2026-10-06.
This file: Overview · Past · Present · Future · Filings · every company on file
Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.